Four years after India allowed 100% foreign direct investment (FDI) in the medical device industry through the “automatic route” requiring no government approval, inflows have crashed.
The Indian association representing multinational medical technology firms blames government price controls imposed on prices of stents and knee
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?